Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
04:01pm, Wednesday, 28'th Sep 2022 The Motley Fool
Positive results for Biogen's Alzheimer's disease candidate are boosting all three stocks.
Biogen's (BIIB) Lecanemab Meets Goal in Alzheimer's Study
03:46pm, Wednesday, 28'th Sep 2022 Zacks Investment Research
Biogen (BIIB) and Eisai's Clarity AD study showed that treatment with lecanemab in the early stages of Alzheimer's disease reduces the rate of clinical decline on the CDR-SB scale by 27% compared to p
4 Alzheimer’s Penny Stocks To Watch After Biogen Stock Explodes
02:56pm, Wednesday, 28'th Sep 2022 PennyStocks
Penny stocks to buy [or avoid] after Biogen Alzheimer's news.
The post 4 Alzheimer’s Penny Stocks To Watch After Biogen Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Informat
14 Analysts Have This to Say About Biogen
02:08pm, Wednesday, 28'th Sep 2022 Benzinga
Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
6
4
0
0
Last 30D
1
4
Here's why one strategist says the consumer and related stocks might get a second wind
02:05pm, Wednesday, 28'th Sep 2022 MarketWatch
It's a tough time for the consumer, but not all is lost, says Jefferies, which is touting some potential good news in the pipeline.
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
02:01pm, Wednesday, 28'th Sep 2022 Benzinga
Upgrades
According to B of A Securities, the prior rating for Prothena Corp PLC (NASDAQ:PRTA) was changed from Neutral to Buy. Prothena Corp earned $0.88 in the second quarter, compared to $0.58 in th
These Analysts Boost Price Targets On Biogen Following Positive Alzheimer's Drug Data, Shares Jump
01:54pm, Wednesday, 28'th Sep 2022 Benzinga
Biogen, Inc. (NASDAQ: BIIB) shares jumped sharply on Wednesday.
The stock was reacting to a positive late-stage readout for the company’s anti-amyloid antibody treatment candidate for slowing the pr
New Alzheimer's drug slows disease in major clinical trial: ‘Blockbuster potential'
01:43pm, Wednesday, 28'th Sep 2022
Patients taking the drug showed a 27% decrease in cognitive decline, compared to a control group.
Biotech Stocks LLY, ESALY Gain on Biogen's Positive Trial Results
01:39pm, Wednesday, 28'th Sep 2022
Amid a notable positive session for the major equity indices, Biogen (NASDAQ: BIIB ) really got the party started with a massive 37% boost in the early afternoon session on Wednesday. Biogen disclosed
Netflix To Rally Around 24%? Here Are 5 Other Price Target Changes For Wednesday
01:22pm, Wednesday, 28'th Sep 2022 Benzinga
Atlantic Equities raised Netflix, Inc. (NASDAQ: NFLX) price target from $211 to $283. Atlantic Equities analyst Hamilton Faber also upgraded the stock from Neutral to Overweight. Netflix shares rose
A Biotech Breakthrough Means Big Gains for These 2 Stocks
01:16pm, Wednesday, 28'th Sep 2022 The Motley Fool
The news could be good for patients suffering from a debilitating disease.
Alzheimer's Blockbuster Might Spur Investor Bonanza, Higher Medicare Costs
01:06pm, Wednesday, 28'th Sep 2022
Biogen's Alzheimer's drug results are breathing new life into a class of anti-amyloid drugs that had been partially written off.
Biogen's (BIIB) Lecanemab Meets Goal in Alzheimer's Study
12:47pm, Wednesday, 28'th Sep 2022
Biogen (BIIB) and Eisai's Clarity AD study showed that treatment with lecanemab in the early stages of Alzheimer's disease reduces the rate of clinical decline on the CDR-SB scale by 27% compared to p
Biogen stock shot up 40% on Wednesday: find out why
12:27pm, Wednesday, 28'th Sep 2022
Shares of Biogen Inc (NASDAQ: BIIB) shot up 40% on Wednesday after the biotech firm said its experimental Alzheimer's drug showed promising results in a Phase III trial.
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
12:01pm, Wednesday, 28'th Sep 2022
Positive results for Biogen's Alzheimer's disease candidate are boosting all three stocks.
